|
Volumn 37, Issue 3, 2005, Pages 1482-1483
|
Effectiveness of pegylated interferon and ribavirin in patients with liver HCV cirrhosis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
PEGINTERFERON;
PEGINTERFERON ALPHA2B;
RIBAVIRIN;
ABSCESS;
ADULT;
AGED;
ANEMIA;
ANOREXIA;
ASTHENIA;
CACHEXIA;
CELLULITIS;
CLINICAL ARTICLE;
CONFERENCE PAPER;
CONTROLLED STUDY;
DRUG DOSE REDUCTION;
DRUG EFFICACY;
DRUG RESPONSE;
FEMALE;
FEVER;
GENOTYPE;
HEPATITIS C VIRUS;
HUMAN;
INFECTION;
LEUKOPENIA;
LIVER BIOPSY;
LIVER CELL CARCINOMA;
LIVER CIRRHOSIS;
LIVER TRANSPLANTATION;
MALE;
NAUSEA;
PATIENT;
PNEUMONIA;
POLYMERASE CHAIN REACTION;
PREDICTION;
PRIORITY JOURNAL;
SCORING SYSTEM;
SIDE EFFECT;
THROMBOCYTOPENIA;
VOMITING;
WEIGHT REDUCTION;
ADULT;
AGED;
DRUG THERAPY, COMBINATION;
FEMALE;
HEPATITIS C;
HUMANS;
INTERFERON ALFA-2B;
LIVER CIRRHOSIS;
LIVER TRANSPLANTATION;
MALE;
MIDDLE AGED;
RIBAVIRIN;
TREATMENT OUTCOME;
|
EID: 21044434616
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2005.02.041 Document Type: Conference Paper |
Times cited : (11)
|
References (7)
|